Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles

Biomaterials

Volumn 29, Issue 17, 2008, Pages 2663-2672

  Pan, Jie ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biodegradable polymers; Breast cancer; Cancer nanotechnology; Nanobiotechnology; Nanomedicine

Indexed keywords

BIODEGRADABLE POLYMERS; DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOBIOTECHNOLOGY; ONCOLOGY; POLYMER BLENDS; VITAMINS;

BREAST CANCER; CANCER NANOTECHNOLOGY; PACLITAXEL CONCENTRATION; POLYLACTIDES;

NANOPARTICLES;

ALPHA TOCOPHEROL; COPOLYMER; COUMARIN; FOLIC ACID; MACROGOL; NANOPARTICLE; PACLITAXEL; POLYLACTIDE; SUCCINIC ACID; TOCOFERSOLAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; GLIOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; FOLIC ACID; HUMANS; MOLECULAR STRUCTURE; NANOPARTICLES; NANOTECHNOLOGY; PACLITAXEL; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; SPECTRUM ANALYSIS; VITAMIN E;

EID: 41949133558     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.02.020     Document Type: Article

References (47)

1. Feng S.S., and Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chemical Engineering Science 58 (2003) 4087-4114
2. Feng S.S., Zhao L.Y., Zhang Z.P., Bhakta G., Win K.Y., Dong Y.C., et al. Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo. Chemical Engineering Science 62 (2007) 6641-6648
3. Feng S.S. New-concept chemotherapy by nanoparticles of biodegradable polymers - where are we now?. Nanomedicine 1 3 (2006) 297-309
4. Feng S.S. Nanoparticles of biodegradable polymers for new concept chemotherapy. Expert Review of Medical Devices 1 1 (2004) 115-125
5. Duncan R. The dawning era of polymer therapeutics. Nature Reviews Drug Discovery 2 5 (2003) 347-360
6. Jain R.K. Transport of molecules, particles, and cells in solid tumors. Annual Review of Biomedical Engineering 1 (1999) 241-263
7. Jain R.K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. Journal of Controlled Release 74 1-3 (2001) 7-25
8. Yamamoto Y., Nagasaki Y., Kato Y., Sugiyama Y., and Kataoka K. Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge. Journal of Controlled Release 77 1-2 (2001) 27-38
9. Park E.K., Kim S.Y., Lee S.B., and Lee Y.M. Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. Journal of Controlled Release 109 1-3 (2005) 158-168
10. Park E.K., Lee S.B., and Lee Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 26 9 (2005) 1053-1061
11. Yoo H.S., and Park T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. Journal of Controlled Release 100 2 (2004) 247-256
12. Yoo H.S., and Park T.G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. Journal of Controlled Release 96 2 (2004) 273-283
13. Nasongkla N., Shuai X., Ai H., Weinberg B.D., Pink J., Boothman D.A., et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angewandte Chemie International Edition 43 46 (2004) 6323-6327
14. Jeong Y.I., Seo S.J., Park I.K., Lee H.C., Kang I.C., Akaike T., et al. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. International Journal of Pharmaceutics 296 1-2 (2005) 151-161
15. Jule E., Nagasaki Y., and Kataoka K. Surface plasmon resonance study on the interaction between lactose-installed poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles and lectins immobilized on a gold surface. Langmuir 18 26 (2002) 10334-10339
16. Jule E., Nagasaki Y., and Kataoka K. Lactose-installed poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface. A surface plasmon resonance study. Bioconjugate Chemistry 14 1 (2003) 177-186
17. Nagasaki Y., Yasugi K., Yamamoto Y., Harada A., and Kataoka K. Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules. Biomacromolecules 2 4 (2001) 1067-1070
18. Yasugi K., Nakamura T., Nagasaki Y., Kato M., and Kataoka K. Sugar-installed polymer micelles: synthesis and micellization of poly(ethylene glycol)-poly(d,l-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 32 24 (1999) 8024-8032
19. Kabanov A.V., Chekhonin V.P., Alakhov V.Y., Batrakova E.V., Lebedev A.S., Meliknubarov N.S., et al. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles - micelles as microcontainers for drug targeting. FEBS Letters 258 2 (1989) 343-345
20. Torchilin V.P., Lukyanov A.N., Gao Z.G., and Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proceedings of the National Academy of Sciences of the United States of America 100 10 (2003) 6039-6044
21. Farokhzad O.C., Cheng J.J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proceedings of the National Academy of Sciences of the United States of America 103 16 (2006) 6315-6320
22. Farokhzad O.C., Jon S.Y., Khadelmhosseini A., Tran T.N.T., LaVan D.A., and Langer R. Nanopartide-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Research 64 21 (2004) 7668-7672
23. Leamon C.P., and Reddy J.A. Folate-targeted chemotherapy. Advanced Drug Delivery Reviews 56 8 (2004) 1127-1141
24. Lu Y.J., and Low P.S. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. Journal of Controlled Release 91 1-2 (2003) 17-29
25. Lu Y.J., Sega E., Leamon C.P., and Low P.S. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Advanced Drug Delivery Reviews 56 8 (2004) 1161-1176
26. Saul J.M., Annapragada A., Natarajan J.V., and Bellamkonda R.V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. Journal of Controlled Release 92 1-2 (2003) 49-67
27. Sudimack J., and Lee R.J. Targeted drug delivery via the folate receptor. Advanced Drug Delivery Reviews 41 2 (2000) 147-162
28. Ross J.F., Chaudhuri P.K., and Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant-tissues in vivo and in established cell-lines - physiological and clinical implications. Cancer 73 9 (1994) 2432-2443
29. Lee Y.K. Preparation and characterization of folic acid linked poly(l-glutamate) nanoparticles for cancer targeting. Macromolecular Research 14 3 (2006) 387-393
30. Shmeeda H., Mak L., Tzemach D., Astrahan P., Tarshish M., and Gabizon A. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Molecular Cancer Therapeutics 5 4 (2006) 818-824
31. Wu J., Liu Q., and Lee R.J. A folate receptor-targeted liposomal formulation for paclitaxel. International Journal of Pharmaceutics 316 1-2 (2006) 148-153
32. Gref R., Domb A., Quellec P., Blunk T., Muller R.H., Verbavatz J.M., et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Advanced Drug Delivery Reviews 16 2-3 (1995) 215-233
33. Traber M.G., Schiano T.D., Steephen A.C., Kayden H.J., and Shike M. Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome. American Journal of Clinical Nutrition 59 6 (1994) 1270-1274
34. Feng S.S., Mu L., Win K.Y., and Huang G.F. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Current Medicinal Chemistry 11 4 (2004) 413-424
35. Khin Y.W., and Feng S.S. In vitro and in vivo studies on vitamin E TPGS-emulsifed poly(d,l-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27 (2006) 2285-2291
36. Bogman K., Erne-Brand F., Alsenz J., and Drewe J. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. Journal of Pharmaceutical Sciences 92 6 (2003) 1250-1261
37. Bogman K., Zysset Y., Degen L., Hopfgartner G., Gutmann H., Alsenz J., et al. P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clinical Pharmacology & Therapeutics 77 1 (2005) 24-32
38. Dintaman J.M., and Silverman J.A. Inhibition of P-glycoprotein by d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharmaceutical Research 16 10 (1999) 1550-1556
39. Rege B.D., Kao J.P.Y., and Polli J.E. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. European Journal of Pharmaceutical Sciences 16 4-5 (2002) 237-246
40. Zhang Z.P., SH L., and Feng S.S. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28 10 (2007) 1889-1899
41. Zhang Z.P., and Feng S.S. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27 21 (2006) 4025-4033
42. Lee E.S., Na K., and Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. Journal of Controlled Release 91 1-2 (2003) 103-113
43. ®): PLGA nanoparticles containing vitamin E TPGS. Journal of Controlled Release 86 1 (2003) 33-48
44. Khin Y.W., and Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 2713-2722
45. Mo Y., and Lim L.Y. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. Journal of Controlled Release 108 2-3 (2005) 244-262
46. Zhang Z.P., and Feng S.S. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 27 2 (2006) 262-270
47. ®). Journal of Controlled Release 80 1-3 (2002) 129-144